These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3181277)
1. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation. Adamus WS; Heuer H; Meade CJ; Frey G; Brecht HM Eur J Clin Pharmacol; 1988; 35(3):237-40. PubMed ID: 3181277 [TBL] [Abstract][Full Text] [Related]
2. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers. Adamus WS; Heuer H; Meade CJ Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings. Adamus WS; Heuer HO; Meade CJ; Schilling JC Clin Pharmacol Ther; 1990 Apr; 47(4):456-62. PubMed ID: 2328553 [TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and pharmacologic activity of multiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects. Adamus WS; Heuer H; Meade CJ; Brecht HM Clin Pharmacol Ther; 1989 Mar; 45(3):270-6. PubMed ID: 2920502 [TBL] [Abstract][Full Text] [Related]
5. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914 [TBL] [Abstract][Full Text] [Related]
7. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man. Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man. Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331 [TBL] [Abstract][Full Text] [Related]
11. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways. Johnson PR; Armour CL; Black JL Eur Respir J; 1990 Jan; 3(1):55-60. PubMed ID: 2311732 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan. Martins MA; Silva PM; Faria Neto HC; Bozza PT; Dias PM; Lima MC; Cordeiro RS; Vargaftig BB Br J Pharmacol; 1989 Feb; 96(2):363-71. PubMed ID: 2924083 [TBL] [Abstract][Full Text] [Related]
13. Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086. Lohmann HF; Adamus WS; Meade CJ Lancet; 1988 Nov; 2(8620):1147. PubMed ID: 2903365 [No Abstract] [Full Text] [Related]
14. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Pretolani M; Lefort J; Malanchère E; Vargaftig BB Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man. Brecht HM; Adamus WS; Heuer HO; Birke FW; Kempe ER Arzneimittelforschung; 1991 Jan; 41(1):51-9. PubMed ID: 1646613 [TBL] [Abstract][Full Text] [Related]
17. Combined effect of Web 2086 (Paf antagonist) and ketoprofen (Nsaid) on Paf-induced ex vivo platelet aggregation in bovine. Bastos da Silva M; Herion F; Raskinet R; David JL; Gustin P; Lekeux P Zentralbl Veterinarmed A; 1997 Apr; 44(2):65-71. PubMed ID: 9284631 [TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists. Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB Braz J Med Biol Res; 1987; 20(5):595-7. PubMed ID: 3452452 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse. Foster AP; Cunningham FM; Andrews MJ; Lees P J Vet Pharmacol Ther; 1993 Dec; 16(4):477-87. PubMed ID: 8126765 [TBL] [Abstract][Full Text] [Related]
20. The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves. Bastos da Silva MB; Gustin P; Herion F; Raskinet R; David JL; Gougnard T; Plomteux G; Desmecht D; Lekeux P Vet Res Commun; 1997 Oct; 21(7):521-31. PubMed ID: 9345719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]